Active Surveillance for Neuroendocrine Tumors of the GI Tract

In some cases, we recommend observation as a reasonable option for islet cell tumors of the pancreas. They are often slow growing, and this way you can avoid some of the side effects of more challenging treatments.

Terry C. Lairmore, MD, Endocrine Surgeon and Chief of Surgical Oncology

In some cases, your Integrated Care Team may recommend the active surveillance of your islet cell tumors of the pancreas.

Active surveillance means careful watching and waiting. Your physician will monitor the course of your disease, intervening with treatment if your tumor begins to grow or becomes aggressive.

Active surveillance may be recommended if you have:

  • A slow-growing islet cell tumor of the pancreas
  • Health limitations that prohibit other treatments

Active surveillance is generally not considered a good option if you have a:

  • Fast-growing tumor
  • Tumor larger than 2 centimeters

Active surveillance often includes:

  • Regular imaging studies
  • Routine check-ups

Back to Top

Text Size